The deal, which features up to $385 million in milestones, gives Biogen exclusive rights to commercialize Stoke’s ...

Several Stoke-on-Trent criminals will be released early following a change made to prison sentences in order to tackle ...

Norwich City FC are all set to lock horns with Stoke City FC in match week 34 of the EFL Championship 2024-25 edition.

Chardan Capital reissued their buy rating on shares of Stoke Therapeutics (NASDAQ:STOK – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a $24 ...

Former Stoke City players have paid tribute to club legend George Eastham at a memorial service to celebrate his ...

From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...

The school leaders taking unprecedented action to ensure a safe learning environment with amenities in good working order ...

Biogen and Stoke partner on zorevunersen for Dravet syndrome, with a Phase 3 trial starting in 2025. Stoke gets $165 million ...

Norwich City are unbeaten across their past eight league games against Stoke City (W5 D3), scoring 3+ goals in four of those ...

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...

Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...

Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...